Q BioMed Inc. (QBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
Q BioMed Market Cap
Q BioMed has a market cap or net worth of $145.00 as of August 22, 2025. Its market cap has decreased by -99.90% in one year.
Market Cap
145.00
Enterprise Value
n/a
Revenue
209.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 17, 2015, Q BioMed's market cap has decreased from 12.19M to 145.00, a decrease of -100.00%. That is a compound annual growth rate of -67.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 145.00 | - |
| Dec 31, 2024 | 145.00 | -99.75% |
| Dec 29, 2023 | 58.04K | -93.87% |
| Dec 30, 2022 | 947.29K | -92.38% |
| Dec 31, 2021 | 12.44M | -46.16% |
| Dec 31, 2020 | 23.10M | -38.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 603.43M |
| Nika Pharmaceuticals | 453.04M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |